DEVELOPMENTS IN CARDIAC TRANSPLANTATION

Cardiac transplantation has matured as a therapeutic intervention, all owing definitive treatment of critically ill children and adults with end-stage heart disease. The ongoing critical shortage of donor organs continues to deny hundreds of individuals access to this intervention . Accordingly, many of the most meaningful recent advances made in the field of cardiac transplantation involve means of expanding our donor pool. While current immunosuppressive regimens have been considerably successful in the management of acute cellular rejection, management of the problems of acute and chronic vascular rejection remains disapp ointing. Advances in this arena remain particularly urgent for physici ans and surgeons involved in the care of heart transplant recipients.